annual EBIT:
-$201.14M-$29.19M(-16.98%)Summary
- As of today (September 15, 2025), CNTA annual earnings before interest & taxes is -$201.14 million, with the most recent change of -$29.19 million (-16.98%) on December 31, 2024.
- During the last 3 years, CNTA annual EBIT has fallen by -$61.83 million (-44.38%).
- CNTA annual EBIT is now -6258.34% below its all-time high of -$3.16 million, reached on December 31, 2020.
Performance
CNTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$55.30M-$24.40M(-78.99%)Summary
- As of today (September 15, 2025), CNTA quarterly earnings before interest & taxes is -$55.30 million, with the most recent change of -$24.40 million (-78.99%) on June 1, 2025.
- Over the past year, CNTA quarterly EBIT has dropped by -$11.27 million (-25.60%).
- CNTA quarterly EBIT is now -291.22% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$206.96M-$11.27M(-5.76%)Summary
- As of today (September 15, 2025), CNTA TTM earnings before interest & taxes is -$206.96 million, with the most recent change of -$11.27 million (-5.76%) on June 1, 2025.
- Over the past year, CNTA TTM EBIT has dropped by -$51.41 million (-33.05%).
- CNTA TTM EBIT is now -815.64% below its all-time high of $28.92 million, reached on December 1, 2020.
Performance
CNTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CNTA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.0% | -25.6% | -33.0% |
| 3 y3 years | -44.4% | +18.5% | +2.2% |
| 5 y5 years | -3969.2% | -291.2% | -815.6% |
CNTA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -44.4% | +4.3% | -79.0% | +25.2% | -33.0% | +6.8% |
| 5 y | 5-year | -6258.3% | +4.3% | -291.2% | +25.2% | -815.6% | +6.8% |
| alltime | all time | -6258.3% | +4.3% | -291.2% | +25.2% | -815.6% | +6.8% |
CNTA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$55.30M(+79.0%) | -$206.96M(+5.8%) |
| Mar 2025 | - | -$30.90M(-58.2%) | -$195.69M(-2.6%) |
| Dec 2024 | -$201.14M(+17.0%) | -$73.89M(+57.6%) | -$200.87M(+23.6%) |
| Sep 2024 | - | -$46.88M(+6.5%) | -$162.46M(+4.4%) |
| Jun 2024 | - | -$44.03M(+22.1%) | -$155.56M(-2.0%) |
| Mar 2024 | - | -$36.07M(+1.6%) | -$158.70M(-7.7%) |
| Dec 2023 | -$171.95M(-18.2%) | -$35.48M(-11.2%) | -$171.95M(-3.6%) |
| Sep 2023 | - | -$39.98M(-15.3%) | -$178.38M(-4.6%) |
| Jun 2023 | - | -$47.17M(-4.4%) | -$187.02M(-9.9%) |
| Mar 2023 | - | -$49.32M(+17.7%) | -$207.66M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$210.15M(+50.8%) | -$41.91M(-13.8%) | -$209.29M(-5.7%) |
| Sep 2022 | - | -$48.61M(-28.3%) | -$222.02M(+4.9%) |
| Jun 2022 | - | -$67.82M(+33.1%) | -$211.56M(+21.8%) |
| Mar 2022 | - | -$50.94M(-6.8%) | -$173.65M(+22.5%) |
| Dec 2021 | -$139.31M(+4303.9%) | -$54.65M(+43.3%) | -$141.73M(+143.7%) |
| Sep 2021 | - | -$38.14M(+27.5%) | -$58.16M(+190.5%) |
| Jun 2021 | - | -$29.92M(+57.3%) | -$20.02M(-302.2%) |
| Mar 2021 | - | -$19.02M(-165.8%) | $9.90M(-65.8%) |
| Dec 2020 | -$3.16M(-36.0%) | - | - |
| Dec 2020 | - | $28.92M | $28.92M |
| Dec 2019 | -$4.94M | - | - |
FAQ
- What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
- What is the all time high annual EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
- What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Centessa Pharmaceuticals plc?
- What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
What is Centessa Pharmaceuticals plc annual earnings before interest & taxes?
The current annual EBIT of CNTA is -$201.14M
What is the all time high annual EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high annual earnings before interest & taxes is -$3.16M
What is Centessa Pharmaceuticals plc annual EBIT year-on-year change?
Over the past year, CNTA annual earnings before interest & taxes has changed by -$29.19M (-16.98%)
What is Centessa Pharmaceuticals plc quarterly earnings before interest & taxes?
The current quarterly EBIT of CNTA is -$55.30M
What is the all time high quarterly EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc quarterly EBIT year-on-year change?
Over the past year, CNTA quarterly earnings before interest & taxes has changed by -$11.27M (-25.60%)
What is Centessa Pharmaceuticals plc TTM earnings before interest & taxes?
The current TTM EBIT of CNTA is -$206.96M
What is the all time high TTM EBIT for Centessa Pharmaceuticals plc?
Centessa Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $28.92M
What is Centessa Pharmaceuticals plc TTM EBIT year-on-year change?
Over the past year, CNTA TTM earnings before interest & taxes has changed by -$51.41M (-33.05%)